Literature DB >> 6158228

Comparison of patch test results in two adjacent areas of England. II. Medicaments.

J D Wilkinson, E M Hambly, D S Wilkinson.   

Abstract

A 3-year study of patch test reactions to the Standard European Battery (S. E. B.) has been carried out in two adjacent areas of South-east England with the same climatic and cultural background. The source of materials and method of testing were identical; all observers have worked together in the same Contact Dermatitis Clinic and the interpretation of reactions can therefore be considered to be consistent. The main differences between the two areas lay in the pattern of employment and in local prescribing habits. Only the second aspect is considered here. Seven allergens--lanolin, neomycin, parabens, iodochlorhydroxyquinoline, ethylene diamine, caine 'mix' and chlorocresol--accounted for approximately 30% of all positive patch test reactions. 'Medicament sensitivity' correlated well with the known prescribing habits of both regions. Certain sites were shown to be especially important in the pathogenesis of medicament contact sensitivity.

Entities:  

Mesh:

Year:  1980        PMID: 6158228

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  Etiologic and causative factors in perianal dermatitis: results of a prospective study in 126 patients.

Authors:  Birger Kränke; Michaela Trummer; Eva Brabek; Peter Komericki; Theo Dieter Turek; Werner Aberer
Journal:  Wien Klin Wochenschr       Date:  2006-03       Impact factor: 1.704

2.  Medicament contact dermatitis in patients with chronic inflammatory ear disease.

Authors:  R C Holmes; A N Johns; J D Wilkinson; M M Black; R J Rycroft
Journal:  J R Soc Med       Date:  1982-01       Impact factor: 18.000

3.  Cow's Milk Allergy Is a Major Contributor in Recurrent Perianal Dermatitis of Infants.

Authors:  Mostafa Abdel-Aziz El-Hodhod; Ahmad Mohamed Hamdy; Marwa Talaat El-Deeb; Mohamed O Elmaraghy
Journal:  ISRN Pediatr       Date:  2012-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.